Cancer Therapeutics Training (CT2) Talk | David Tyvoll, PhD and Kyle Bohnert, PhD

Monday, November 2, 2026 at 12:00 PM PT

Comer Commons, Moores Cancer Center · UC San Diego · San Diego

The Development of Pharmaceutical Inhibitors of the IRE1a/XBP1s Arm of the Unfolded Protein Response to Prevent Skeletal Muscle Loss During Cancer Cachexia David Tyvoll, PhD is a physical chemist. He completed his undergraduate degree at UCSD, earned his PhD at Stanford as well as completed post-doc